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Methods. This was a one-group pretest-posttest design study. A multidisciplinary team developed a chronic pain educational package for general practitioner trainees emphasizing limitations, riskmitigation, and deprescribing of opioids with transition to active self-care. This educational intervention incorporated prereadings, a resource kit, and a 90-minute interactional video case-based workshop incorporated into an education day. Evaluation was via pre-and postintervention (two months) questionnaires. Differences in management of two clinical vignettes were tested using McNemar's test.
Results. Of 58 eligible trainees, 47 (response rate 5 81.0%) completed both questionnaires (36 of whom attended the workshop). In a primary analysis including these 47 trainees, therapeutic intentions of tapering opioid maintenance for pain (in a paperbased clinical vignette) increased from 37 (80.4%) pre-intervention to 44 (95.7%) postintervention (P 5 0.039). In a sensitivity analysis including only trainees attending the workshop, 80.0% preintervention and 97.1% postintervention tapered opioids (P 5 0.070). Anticipated initiation of any opioids for a chronic osteoarthritic knee pain clinical vignette reduced from 35 (74.5%) to 24 (51.1%; P 5 0.012) in the primary analysis and from 80.0% to 41 .7% in the sensitivity analysis (P 5 0.001).
Introduction
The provision of analgesia has always been a staple responsibility for doctors, with estimates of the prevalence of painful conditions among American adults as high as 43% [1] . What constitutes quality analgesia has changed over time in response to prevailing advocacy, cultural beliefs, and education about which is the lesser of two evils: the suffering of pain or the deployment of opioids, the latter being coupled with addiction fears [1] [2] [3] .
For much of the twentieth century in the West, opioids were considered too dangerous even to use in end-oflife cancer patients [4] . The hospice movement revolutionized analgesia for the dying by advocating successfully for liberal access to opioids. In the 1980s, the newly formed speciality of pain medicine argued that pain was not just a sign but a disease that was undertreated [2] . Furthermore, chronic noncancer pain (CNCP) should be, and could be, effectively treated by the "proper" integration of opioids, albeit with education to help physicians overcome their "misunderstandings" and "fear of addiction" [2, 3, [5] [6] [7] . Management principles for palliative care were conflated with those for CNCP and still are [8] . This is despite insufficient to low levels of evidence supporting the efficacy of opioids in CNCP and emerging evidence of associations between longer durations of opioid usage and harms such as hyperalgesia or addiction [1, 9] . Opioid use for CNCP has become commonplace, with 3% to 4% of adult Americans prescribed long-term opioid analgesia in 2005 [1] and 11.8% of Australian general practice (GP) patients reporting their use in the previous year [10] . Australian opioid dispensing levels increased four-fold from 1990 to 2014 [11] . As in the United States, increasing opioid analgesic prescribing in Australia has been related to increasing presentations for opioid analgesic dependency management [12] and increasing opioid-related hospitalizations and accidental deaths [13] . The latter are now predominantly from pharmaceutical opioids rather than heroin [13, 14] . The differentiation between pharmaceutical and illicit opioids has become blurred due to their similar pharmacodynamics and increased availability for misuse [1] . Transitions from the misuse of opioid analgesics to the initiation of heroin use have been documented [15] . Those who have misused opioid analgesics are 19 times more likely to initiate heroin use [16] .
Some have expressed concern that reductions in liberal opioid prescribing will be replaced by increased consumption of heroin [17] . However, across 28 US states, there have been dramatic increases in drug-related overdoses involving both heroin and opioid analgesics [18] . Opioid analgesic prescribing rates vary significantly across Australia, potentially indicating unwarranted or inappropriate prescribing and risks of increased harms [19] . With up to a 10-fold prescribing rate difference between localities, higher prescribing rates are found in more rural localities and areas of lower socioeconomic status [19] [20] [21] . Contributing to this variation are prescribing practices, training, knowledge, and attitudes of GPs [19] . Previous cross-sectional data involving GP trainees have shown increased opioid prescribing associated with patient age, male gender, and Aboriginal or Torres Islander status, as well as more rural or disadvantaged localities [21] . To reduce the overmedication of CNCP, the Faculty of Pain Medicine of the Australian and New Zealand College of Anaesthetists (ANZCA) has stated that "it is clear that opioid pharmacotherapy cannot be considered to be a core component of the management of CNCP" [22] . US guidelines go further, indicating in CNCP opioids are "rarely" needed for durations of more than seven days [1] .
One of the main "crises" impeding the improvement of pain management today is the inadequacy of education for primary care [3, 23] . The US Food and Drug Administration has made continuing medical education (CME) on CNCP central to their Risk Evaluation and Mitigation Strategy (REMS) [24] . The evidence base to determine their most effective form, duration, and provenance, however, is lacking. A systematic review identified 19 studies, but meta-analysis was precluded by the heterogeneity of methodological designs and quality, subject matter, and outcome measures [25] . Based on pre-/postassessment outcome measures, improved clinician knowledge and attitudes have been shown among US hospital residents after two hours of face-to-face or web-based training [26, 27] , Australian GPs after 6.5 hours of training [28] , US physicians (sanctioned for misprescribing) after three days of training [29] , and REMS participants [30] . A trial among German GPs on lumbago care found that three interactive seminars plus two academic detailing visits improved patient outcomes at six months compared with the receipt of posted guidelines [31] .
Educators of doctors-in-training have been said to have a moral obligation to assume responsibility for improved CNCP care [3] . In order to address the evidence gap in evaluations of continuing medical education on CNCP, we set out to develop, deliver, and evaluate a brief multifaceted non-commercially funded CNCP educational intervention for GPs undergoing vocational training. We aimed to determine whether this intervention, when embedded in a routine training day, reduced the hypothetical opioid prescribing of GP trainees.
Methods
We performed a questionnaire-based evaluation of a pragmatic intervention, delivered to GP trainees in the course of their usual training, using a one-group pretest-posttest study design.
Study Population and Recruitment
The study population was GP registrars (vocational trainees) in one of Australia's 17 Regional Training Providers. These are government-funded, not-for-profit, geographically defined organizations charged (until 2016) with delivery of general practice vocational training. Trainees eligible for this study were in one of the first two of their three mandatory general practicebased training terms. Each term lasts a full-time equivalent of six months and is undertaken after at least two years spent in hospital training.
Trainee inclusion criteria were term 1 and 2 trainees eligible to attend a workshop conducted as part of their vocational training program. All trainees were invited at a previous workshop or via email or post to complete a study questionnaire before the intervention, as well as to complete a questionnaire two months afterwards.
Intervention
The intervention aimed to improve CNCP guideline concordance by emphasizing the transition to active selfmanagement, opioid deprescribing, and the use of opioid prescribing boundaries. It comprised:
1. Selected papers provided online as prereading for the educational session 2. A 90-minute face-to-face educational session conducted as part of a day-long educational release workshop 3. Participant resources to facilitate implementation of guideline-endorsed pain management strategies, provided online postworkshop A multidisciplinary group contributed to the preparation of the intervention package. The group included a pain physician, two addiction physicians, a public health physician, a psychologist, and several GP medical educators.
Prereading
Readings covered the history, science, and culture of opioid use in CNCP [32] ; the integration of the principles of pain medicine and addiction medicine into CNCP management [33] ; shared CNCP decision-making [34] ; and an introduction to motivational interviewing [35] .
Workshop Sessions
Workshop content is summarized in Box 1. Following the lead of Sullivan [27] , we developed four two-to three-minute videoed vignettes. These aimed to increase immediacy, to illustrate negotiation skills, and to enhance group discussion. The vignettes involved an actor playing the patient and a GP trainee supervisor playing a doctor commencing at the practice. The first visit involved the doctor running late and seeing an inherited CNCP patient for the first time. The doctor was given numerous challenges to manage including a request for routine repeat oxycodone prescription. The next two scenes in the video vignette showed the patient-centred development of functional goals, an opioid agreement, the implementation of monitoring based on the four "A's" of Passik [6] . Things went
Box 1 Presentation content
The history of opium and analgesia practice The escalation in the West of opioid prescribing and associated harms, including overdose and addiction Chronic noncancer pain (CNCP) neurophysiology including neuro-plasticity, central sensitization, and opioid-induced hyperalgesia Guideline-concordant and patient-centred management of CNCP Biopsychosocial assessment in CNCP including past and present psychiatric and substance use problems, in preference to tool-based risk stratification (38) Use of the Pain Intensity, Enjoyment of Life, General Activity measurement scale (40) The importance of multidisciplinary and multimodal CNCP management with appropriate referral to physiotherapy, psychology, pain specialists, or addiction treatment services The nonpharmaceutical self-management management of CNCP The nonopioid pharmaceutical management of CNCP The lack of evidence supporting opioids in CNCP in terms of efficacy and safety The practice, principals, and limitations of universal precautions if or when opioids are used in CNCP The importance of assessing and responding to the emergence of aberrant behavior Deprescribing opioids awry with a dose escalation negotiated following pressure from the patient who claimed undertreatment of pain. The final vignette revealed accumulating aberrant behaviors. Discussion between the doctor and patient resulted in agreement to gradually deprescribe (i.e., taper or discontinue) opioids and commence more multimodal care. The videos are freely available from links given in the online sup plementary material. The style of the presentation was interactive, with trainees encouraged to reflect on and compare and contrast their attitudes and practice. Approximately half the duration of the presentation involved viewing the vignettes and discussing them as a group in the context of their own practice. The facilitator linked discussions of each vignette back to the clinical processes described in the presentation, reinforcing the key messages regarding biopsychosocial assessment of CNCP (including psychiatric and substance use problems), assessment of pain and its impact on daily functioning, universal precautions as they apply to opioids, monitoring aberrant behavior, and deprescribing (Box 1).
Postworkshop Resources
Resources provided to trainees, including those absent from the presentation, are listed in Box 2, with links provided in the online supplementary material.
The lead presenter of the educational session was a GP supervisor of trainees and addiction physician (SH). Other presenters were the director of the regional pain service (CH) and the senior medical officer in addiction for the state (AD).
Questionnaires
The multiple-choice questionnaire was developed by the multidisciplinary group. It covered attitudes toward the use of long-term opioids in CNCP, as well as the management of two case-based CNCP clinical vignettes. The vignettes concerned chronic back pain uncontrolled with current opioid medication and knee osteoarthritis pain uncontrolled with nonopioid pharmaceuticals. See Box 3 for the two vignettes.
Outcome Factors
The primary outcome factors addressed our study aim of evaluating whether our intervention reduced the hypothetical opioid prescribing of GP trainees.
The primary outcomes were pre-to postworkshop change in proportion of hypothetical opioid management responses on the two clinical vignettes. The preintervention questionnaires were completed three weeks 
Mrs Bird is a 57-year-old ex-competitive skier. She has a 10-year history of severe osteoarthritis of her lumbar spine with multiple levels involved. She has previously seen an orthopedic surgeon, and her condition is not suitable for surgery. She was prescribed modified-release oxycodone tablets six months ago by another doctor in the practice. Her pain didn't really improve, and now she is experiencing severe back pain. She is currently taking modified-release oxycodone 20 mg bd, regular modified-release paracetamol, and occasional meloxicam 15 mg. There are no red flags that warrant further investigation. Vignette 2 Mr Wilson is age 68 years and has a long history of osteoarthritis particularly affecting his knees. He continues to have mild pain in his right knee and severe pain in his left knee, on which he has had a total knee replacement (one year ago, with a difficult postoperative course leaving him with marked pain and stiffness). The pain causes marked limitation of activities. He takes regular modified-release paracetamol and frequent nonsteroidal anti-inflammatory drugs, with only modest effect on his pain.
prior to the prereading being made available (i.e., four weeks prior to the workshop). The postintervention questionnaires were completed two months postworkshop.
For the chronic back pain vignette, responses were dichotomized to those involving opioid dose maintenance or increase and those entailing dose reduction or cessation. For the opioid-naïve knee osteoarthritis pain vignette, responses were dichotomized to those entailing initiation of an opioid and those not entailing initiation of an opioid. Secondary outcomes were:
1. Changes to proportion of patients for whom individual opioids would be initiated for the opioid-naïve knee osteoarthritis pain vignette 2. Changes to proportion of patients in which referrals to individual medical or allied health services would be made for the opioid-naïve knee osteoarthritis pain vignette 3. Changes in opinions regarding whether opioids are underprescribed or overprescribed in CNCP (scored on a five-point Likert scale from 1 ¼ underprescribed to 5 ¼ overprescribed and later dichotomized to underprescribed/neutral (scores of 3) vs overprescribed scores >3)
Statistical Analyses
Pre-post changes on all parameters were tested using McNemar's test. If cell numbers were small, we used an Exact McNemar's. Our primary analyses included all trainees who provided both pre-intervention and postintervention data, whether or not they had attended the workshop or used the papers or resources. We also performed sensitivity analyses including data of only those trainees who attended the workshop. For all analyses, statistical significance was set at a P value of less than 0.05.
Ethical Approval
Ethics approval for the study was obtained from the Human Research Ethics Committee of the University of Newcastle (approval number: H-2009-0323).
Results
There were 58 registrars enrolled in either term 1 or 2, with 43 attending the workshop. Forty-seven trainees (response rate ¼ 81%) completed both questionnaires (36 of whom attended the workshop). Their demographics may be found in Table 1 . There were no significant differences in the characteristics of those who completed both questionnaires (N ¼ 47) and those who completed a questionnaire at one time point only (N ¼ 11). Responses are given in Table 2 .
Primary Outcomes
For the back pain scenario, there was a decrease in maintaining and/or increasing opioid analgesia. In the primary analysis, there was a statistically significant increase in intended deprescribing of opioids from 37 participants (80.4%) to 44 participants (95.7%; P ¼ 0.039).
Among those who attended the workshop, intentions to deprescribe increased from 28 participants (80.0%) to 34 participants (97.1%; P ¼ 0.070).
For the knee osteoarthritis scenario, there was a statistically significant decrease in the proportion intending to initiate opioids, from 35 participants (74.5%) to 24 participants (51.1%; P ¼ 0.012). Among workshop attendees, intended opioid initiation reduced from 28 participants (80.0%) to 15 participants (41.7%; P ¼ 0.001).
Secondary Outcomes
There was a statistically significant reduction in intended initiation of immediate-release oxycodone (P ¼ 0.004 in the primary analyses and 0.008 among workshop attendees) and a nonsignificant trend to reduced intention to initiate modified-release oxycodone (P ¼ 0.063 in both analyses). There were no significant changes in intention to initiate any other specific opioids or referrals. There was a nonsignificant trend for more registrars to regard opioid analgesics for CNCP as overprescribed (P ¼ 0.248) in primary analyses.
Discussion
A brief educational package on CNCP management was prepared and delivered by a multidisciplinary team.
Responses to the questionnaire two months later showed changed attitudes toward opioid monotherapy, with increased intended deprescribing.
Comparisons with Other Studies
While teaching the curriculum recommended by the International Association for the Study of Pain has been estimated to require up to 74 hours [34] , the brevity of this CNCP education package is meaningful. There is a diversity of approaches by US states to relevant CME for physicians [23] , reflecting the lack of evidence base regarding how much (or how little) education is needed and whether education regarding the role of opioids in the management of CNCP is effective. Very few US states mandate relevant CME and those that do only require one-off or periodic training of a similar duration to this package. Still about half of US physicians report having never undertaken CME on the nonopioid management of CNCP [23] . The US Food and Drug Administration (FDA) planned the REMS CME to be mandatory for opioid prescribers, but almost one-third (31.2%) of Pennsylvanian GPs indicated that they would rather discontinue prescribing opioids altogether than undertake the proposed four to eight hours involved [24]. The REMS has been rolled out as a voluntary three hours of live or online training [30] .
Scenario Management
The duration of opioid maintenance for new episodes of CNCP has been found to be strongly associated with rates of incident opioid use disorders [36] . In the case involving chronic back pain refractory to opioids, trainees in the primary analysis significantly increased their rate of proposed opioid deprescribing. The importance of this is that opioid deprescribing in CNCP is rare among Australian GPs, with 89% in one survey reporting never or only "occasionally" doing so, even when faced with addictive behaviors [37] . GP trainees predominantly prescribe opioids as repeat prescriptions to regular practice CNCP patients [21] , reflecting the significant barriers to deprescribing [38] .
The proposed management of the opioid-naïve knee osteoarthritis pain case saw the number of trainees intending to initiate opioids reduce by approximately one-third and one-half, respectively, in the primary and sensitivity analyses. Recent guidelines do not support the use of opioid analgesics in CNCP, even when envisaged as a time-limited trial [1, 39, 40] . Reduced oxycodone initiation (statistically significant for the immediate-release formulations in our study) is important given that oxycodone has been found to be the second most highly prescribed opioid by trainees [21] and accounted for 38% of the total opioid dispensings in Australia [14] .
Strengths and Limitations
Despite the plethora of mainly commercially funded CNCP educational packages available to GPs, few have been evaluated, with none being evaluated for GP trainees. A strength of our study is that we carefully developed the content and format of the package based on multidisciplinary input, previous pain educational research, and observational data of opioid prescribing in this population [21] . We then tested it in a "real world" situation of GP trainees' routine educational programs.
Conducting an analysis of all trainees-including those who did not receive all or any elements of the intervention-best approximates the real-world logistics of delivering education in vocational education programs. By way of comparison and to better evaluate the efficacy of the actual workshop, we conducted a sensitivity analysis of those trainees who attended the workshops.
A limitation of the study is that our outcome variable was expressed management intentions rather than actual clinical practice (where the practical barriers to deprescribing must be confronted). The sample size, particularly in the sensitivity analysis, may have prevented some effects of the intervention reaching statistical significance. The lack of a control group is also a limitation of the study, but given the short time frame involved, these data are unlikely to reflect more widespread changes in trainee analgesia practice. The parameters of the registrar training day did not allow for more active modalities of learning such as individualized skill rehearsal and feedback, serial online learning units, clinical audits, or educational outreach visits [25] . A further limitation may be social desirability bias of trainees wishing to report changes sanctioned by their educators. Relying on a duration of two months for the administration of our postintervention questionnaire may be regarded either as a strength or a limitation due to the inconsistency of outcomes reported in the literature [25] .
Implications for Practice and Further Research
This study demonstrates how a complex, non-commercially funded educational intervention, delivered as part of a usual education program and with face-to-face contact of only 90 minutes, can change trainees' intended CNCP management. Relevant noncommercial training has been previously associated with better quality CNCP care in terms of increased guideline concordance [37] . Further research has been called for to evaluate changes in actual CNCP management, as opposed to expressed intentions, with the employment of a control group [28] . This should strengthen program development and improve learner, patient, and health care outcomes [29] .
While a reduction of non-evidence-based CNCP management in the form of long-term opioid prescribing is an important goal, it is not the only indicator of quality care. Of crucial importance is the education of GPs about appropriate evidence-based alternatives to opioids. Accessible, pragmatic educational models of nonpharmacologic management of CNCP will have to be constructed, implemented, and evaluated. These would address better patient education about the neurobiology of pain and the need for lifestyle modification, as well as improving GP skills for the psychological and functional management of pain and opioid deprescribing [23] .
Conclusion
Our interactional educational package aimed to both improve CNCP care and reduce poor opioid care. The readings, provision of resources, and the single interactive and vignette-based workshop produced significant changes to trainees' judgments about, and intentions toward, long-term opioid analgesia maintained at two months. It is important that any educational interventions to be disseminated in primary care have effectiveness that is evidence based. The contents and mode of dissemination of models of analgesia education should thus improve patient outcomes and protect them from iatrogenic harm.
